BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jeon HH, Lee HJ, Jang HW, Yoon JY, Jung YS, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis. World J Gastroenterol 2013; 19(2): 265-273 [PMID: 23345950 DOI: 10.3748/wjg.v19.i2.265]
URL: https://www.wjgnet.com/1007-9327/full/v19/i2/265.htm
Number Citing Articles
1
Jin Li, Fan Wang, Hong-Jie Zhang, Jian-Qiu Sheng, Wen-Feng Yan, Min-Xing Ma, Ru-Ying Fan, Fang Gu, Chuan-Feng Li, Da-Fan Chen, Ping Zheng, Yu-Pei Gu, Qian Cao, Hong Yang, Jia-Ming Qian, Pin-Jin Hu, Bing Xia. Corticosteroid therapy in ulcerative colitis: Clinical response and predictorsWorld Journal of Gastroenterology 2015; 21(10): 3005-3015 doi: 10.3748/wjg.v21.i10.3005
2
Heli Eronen, Tuire Ilus, Airi Jussila, Heini Huhtala, Pekka Collin, Pia Oksanen. Long-term outcome of patients with acute ulcerative colitis after first course of intravenous corticosteroidsScandinavian Journal of Gastroenterology 2021; 56(3): 234 doi: 10.1080/00365521.2020.1867892
3
Sinyoung Park, Yang Hee Noh, Sun Young Rha, Won Ho Kim, Jae Hee Cheon. Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center StudyIntestinal Research 2015; 13(3): 274 doi: 10.5217/ir.2015.13.3.274
4
Javier P. Gisbert, Manuel Barreiro-de Acosta, María Esteve, Valle García-Sánchez, Fernando Gomollón, Jordi Guardiola, Joaquin Hinojosa, Maria-Dolores Martín Arranz, Miguel Minguez, Carlos Taxonera, Isabel Vera. Physician Perspectives on Unresolved Issues in the Management of Ulcerative ColitisInflammatory Bowel Diseases 2016; 22(3): 583 doi: 10.1097/MIB.0000000000000617
5
Borja Ocón, Carlos J. Aranda, Reyes Gámez-Belmonte, María Dolores Suárez, Antonio Zarzuelo, Olga Martínez-Augustin, Fermín Sánchez de Medina. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in miceBiochemical Pharmacology 2016; 116: 73 doi: 10.1016/j.bcp.2016.07.010
6
Wei Han, Jian-Ming Xu, Nai-Zhong Hu, Qiao Mei, Ming-Wen Liu. Early predictors of responses and clinical outcomes of corticosteroid treatment for severe ulcerative colitisScandinavian Journal of Gastroenterology 2014; 49(4): 424 doi: 10.3109/00365521.2014.886716
7
Yuki Aoyama, Tomoki Inaba, Sakuma Takahashi, Hisae Yasuhara, Sakiko Hiraoka, Takeshi Morimoto, Hugh Shunsuke Colvin, Masaki Wato, Midori Ando, Satoko Nakamura, Koichi Mizobuchi, Hiroyuki Okada. Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitisBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01903-5
8
Hui-min Wu, Juan Wei, Jin Li, Kai Wang, Lei Ye, Ying Qi, Bo-si Yuan, Yu-lin Yang, Li Zhao, Zhao Yang, Miao-fang Yang, Jian-feng Gong, Fang-yu Wang. Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative ColitisDigestive Diseases and Sciences 2019; 64(11): 3263 doi: 10.1007/s10620-018-5446-0
9
Tarun Rai, Bikash Narayan Choudhury, Saurabh Kedia, Sawan Bopanna, Pratap Mouli Venigalla, Sushil Kumar Garg, Vikas Singla, Govind Makharia, Vineet Ahuja. Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study ExperienceDigestive Diseases and Sciences 2017; 62(4): 1025 doi: 10.1007/s10620-017-4450-0
10
Shuang Liu, Yan You, Gechong Ruan, Liangrui Zhou, Dan Chen, Dong Wu, Xuemin Yan, Shengyu Zhang, Weixun Zhou, Ji Li, Jiaming Qian. The Long-Term Clinical and Endoscopic Outcomes of Cronkhite–Canada SyndromeClinical and Translational Gastroenterology 2020; 11(4): e00167 doi: 10.14309/ctg.0000000000000167
11
Cong Cheng, Dao-Xing Deng, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Yu-Qian Sun, Xiao-Jun Huang, Xiao-Dong Mo. Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatmentFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1390438
12
Shomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, Florian Rieder, Flavio Steinwurz, Konstantinos Karmiris, Jae Hee Cheon, Gordon William Moran, Monica Cesarini, Christian D Stone, Doron Schwartz, Marijana Protic, Xavier Roblin, Giulia Roda, Min-Hu Chen, Ofir Har-Noy, Charles N Bernstein. Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceWorld Journal of Gastroenterology 2017; 23(16): 2995-3002 doi: 10.3748/wjg.v23.i16.2995
13
Jacques Cosnes, Harry Sokol. Crohn's Disease and Ulcerative Colitis2017; : 653 doi: 10.1007/978-3-319-33703-6_61
14
Jaeyoung Chun, Changhyun Lee, Ji-eun Kwon, Sung Wook Hwang, Sang Gyun Kim, Joo Sung Kim, Hyun Chae Jung, Jong Pil Im. Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative ColitisIntestinal Research 2015; 13(1): 50 doi: 10.5217/ir.2015.13.1.50
15
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi, Francesco Costa. Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative ColitisDigestive Diseases and Sciences 2020; 65(8): 2397 doi: 10.1007/s10620-019-05959-y
16
Emre Gerçeker, Serkan Cerrah. Platelet, Mean Platelet Volume and Platelet Distribution Width Levels Might Be a Promising Marker for the Prediction of Disease Severity, Mucosal Healing and Steroid Dependence in Patients With Ulcerative ColitisCureus 2023;  doi: 10.7759/cureus.33286